X-linked recessive ichthyosis: An impaired barrier function evokes limited gene responses before and after moisturizing treatments

British Journal of Dermatology

Volumn 167, Issue 3, 2012, Pages 514-522

  Hoppe, T ^a   Winge, M C G ^b   Bradley, M ^b   Nordenskjold M ^b   Vahlquist, A ^a   Berne, B ^a   Torma H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; FATTY ACID SYNTHASE; FILAGGRIN; GLUCOSYLCERAMIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; OLIGONUCLEOTIDE; STERYL SULFATASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRY SKIN; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; QUANTITATIVE ANALYSIS; SKIN SURFACE; SKIN WATER LOSS; X LINKED ICHTHYOSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DOWN-REGULATION; EMOLLIENTS; GENE EXPRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; ICHTHYOSIS, X-LINKED; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; RNA, MESSENGER; SKIN; STERYL-SULFATASE; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 84865587075     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10979.x     Document Type: Article

References (32)

1. Oji V, Traupe H,. Ichthyoses: differential diagnosis and molecular genetics. Eur J Dermatol 2006; 16: 349-59. (Pubitemid 44328973)
2. Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-42.
3. Irvine AD, McLean WH, Leung DY,. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-27.
4. Shwayder T,. Ichthyosis in a nutshell. Pediatr Rev 1999; 20: 5-12.
5. Winge MC, Hoppe T, Lieden A, et al. Novel point mutation in the STS gene in a patient with X-linked recessive ichthyosis. J Dermatol Sci 2011; 63: 62-4.
6. Elias PM, Williams ML, Holleran WM, et al. Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. J Lipid Res 2008; 49: 697-714.
7. Elias PM, Crumrine D, Rassner U, et al. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004; 122: 314-19. (Pubitemid 38281050)
8. Lavrijsen AP, Oestmann E, Hermans J, et al. Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol 1993; 129: 547-53.
9. Zettersten E, Man MQ, Sato J, et al. Recessive X-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol 1998; 111: 784-90. (Pubitemid 28509319)
10. Liao H, Waters AJ, Goudie DR, et al. Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 2007; 127: 2795-8. (Pubitemid 350134826)
11. Proksch E, Brandner JM, Jensen JM,. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063-72.
12. Törmä H, Berne B,. Sodium lauryl sulphate alters the mRNA expression of lipid-metabolizing enzymes and PPAR signalling in normal human skin in vivo. Exp Dermatol 2009; 18: 1010-15.
13. Törmä H, Lindberg M, Berne B,. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008; 128: 1212-19. (Pubitemid 351543210)
14. Winge MC, Hoppe T, Berne B, et al. The filaggrin genotype determines functional and molecular alterations in the skin of patients with atopic dermatitis and ichthyosis vulgaris. PLoS ONE 2011; 6: e28254.
15. Hernandez-Martin A, Gonzalez-Sarmiento R, De Unamuno P,. X-linked ichthyosis: an update. Br J Dermatol 1999; 141: 617-27. (Pubitemid 29512813)
16. Vahlquist A, Gånemo A, Virtanen M,. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol (Stockh) 2008; 88: 4-14. (Pubitemid 351212127)
17. Buraczewska I, Berne B, Lindberg M, et al. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492-8.
18. Buraczewska I, Berne B, Lindberg M, et al. Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids. Arch Dermatol Res 2009; 301: 587-94.
19. Buraczewska I, Berne B, Lindberg M, et al. Long-term treatment with moisturizers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation. Arch Dermatol Res 2009; 301: 175-81.
20. Törmä H, Geijer S, Gester T, et al. Variations in the mRNA expression of inflammatory mediators, markers of differentiation and lipid-metabolizing enzymes caused by sodium lauryl sulphate in cultured human keratinocytes. Toxicol In Vitro 2006; 20: 472-9.
21. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
22. Öhman H, Vahlquist A,. The pH gradient over the stratum corneum differs in X-linked recessive and autosomal dominant ichthyosis: a clue to the molecular origin of the 'acid skin mantle'? J Invest Dermatol 1998; 111: 674-7. (Pubitemid 28452332)
23. van Esch H, Hollanders K, Badisco L, et al. Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis. Hum Mol Genet 2005; 14: 1795-803. (Pubitemid 41418051)
24. Imamura R, Wang Y, Kinoshita T, et al. Anti-inflammatory activity of PYNOD and its mechanism in humans and mice. J Immunol 2010; 184: 5874-84.
25. Eissa A, Diamandis EP,. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions. Biol Chem 2008; 389: 669-80. (Pubitemid 352009412)
26. Schmuth M, Fluhr JW, Crumrine DC, et al. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol 2004; 122: 909-22. (Pubitemid 38580993)
27. Schmuth M, Yosipovitch G, Williams ML, et al. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 2001; 117: 837-47. (Pubitemid 33001199)
28. Denda M, Fuziwara S, Inoue K,. Influx of calcium and chloride ions into epidermal keratinocytes regulates exocytosis of epidermal lamellar bodies and skin permeability barrier homeostasis. J Invest Dermatol 2003; 121: 362-7. (Pubitemid 36969911)
29. Menon GK, Elias PM, Lee SH, et al. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tissue Res 1992; 270: 503-12.
30. Sato J, Denda M, Nakanishi J, et al. Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum. J Invest Dermatol 1998; 111: 189-93. (Pubitemid 28354701)
31. Gånemo A, Virtanen M, Vahlquist A,. Improved topical treatment of lamellar ichthyosis: a double-blind study of four different cream formulations. Br J Dermatol 1999; 141: 1027-32. (Pubitemid 30046190)
32. Madison KC,. Barrier function of the skin: 'la raison d'etre' of the epidermis. J Invest Dermatol 2003; 121: 231-41. (Pubitemid 36969895)